The slip
PARKINSON RECEIPTno. 9023
24 Oct 2026, 21:11 UTCdopamine neurons, braak
predictionBID in dopamine neurons tracks Braak Lewy-body stage
registered4d2c25c6b5e327be
discovery-0.60 p=0.089 n=9
replication-0.16 p=0.682 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.60, p 0.089)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT2e2a3a8ea9b6b5283f66e539…
follows 4b01f05c87ba…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9023: BID in dopamine neurons, braak
- power
- full sample -0.29 (p 0.235, n 18), 95% CI -0.67 to +0.20. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.39 (p 0.114, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.39 (p 0.109, n 18). could be the mix.
- skeptic
- leave-one-out range -0.49 to -0.20, sign flips 0; without severely affected donors -0.29 (p 0.235, n 18). fragile.
- cell type
- strongest in microglia: -0.61 (p 0.0072, n 18) vs -0.29 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for BID in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up BID · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.20 p 0.477 (needs p < 2.4e-4)